{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:56:38Z","timestamp":1773798998196,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jiac.2022.08.014","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T15:49:11Z","timestamp":1660837751000},"page":"1693-1696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antimicrobial activity of ozenoxacin and other antimicrobials against Staphylococcus aureus strains isolated from clinical skin specimens in Japan in 2019 and 2020"],"prefix":"10.1016","volume":"28","author":[{"given":"Ichiro","family":"Kurokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1595-933X","authenticated-orcid":false,"given":"Osamu","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.08.014_bib1","series-title":"The JAID\/JSC Guide to clinical management of infectious disease 2019: Japanese society of chemotherapy and the Japanese association for infectious disease","first-page":"183","article-title":"Editorial team members of JAID\/JSC guide\/guidelines to clinical management of infectious disease","year":"2019"},{"key":"10.1016\/j.jiac.2022.08.014_bib2","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/1346-8138.15506","article-title":"Current status of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus isolated from patients with skin and soft tissue infections in Japan","volume":"47","author":"Nakaminami","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jiac.2022.08.014_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jac\/49.3.455","article-title":"In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone","volume":"49","author":"Yamakawa","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2022.08.014_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1099\/jmm.0.000293","article-title":"Antimicrobial activities of ozenoxacin against isolates of propionibacteria and staphylococci from Japanese patients with acne vulgaris","volume":"65","author":"Nakajima","year":"2016","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jiac.2022.08.014_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jiac.2016.03.006","article-title":"In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan","volume":"22","author":"Kanayama","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.08.014_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2217\/fmb-2019-0089","article-title":"Microbiological profile of ozenoxacin","volume":"14","author":"Morrissey","year":"2019","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jiac.2022.08.014_bib7","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jac\/dkab098","article-title":"In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007\u201318)","volume":"76","author":"Zhanel","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2022.08.014_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14787210.2019.1573671","article-title":"Ozenoxacin: a review of preclinical and clinical efficacy","volume":"17","author":"Vila","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2022.08.014_bib9","first-page":"279","article-title":"An open-label, phase III study of ozenoxacin lotion in patients with superficial infection of the skin","volume":"31","author":"Kawashima","year":"2015","journal-title":"J Clin Ther Med"},{"key":"10.1016\/j.jiac.2022.08.014_bib10","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI standard M07","year":"2018"},{"key":"10.1016\/j.jiac.2022.08.014_bib11","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI standard M100","year":"2020"},{"key":"10.1016\/j.jiac.2022.08.014_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jiac.2017.05.006","article-title":"The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan","volume":"23","author":"Watanabe","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.08.014_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.36849\/JDD.5745","article-title":"Do antimicrobial resistance patterns matter? An algorithm for the treatment of patients with impetigo","volume":"20","author":"Schachner","year":"2021","journal-title":"J Drugs Dermatol JDD"},{"key":"10.1016\/j.jiac.2022.08.014_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0924-8579(01)00496-4","article-title":"Antimicrobial resistance of Staphylococcus aureus isolated from skin infections","volume":"19","author":"Nishijima","year":"2002","journal-title":"Int J Antimicrob Agents"}],"updated-by":[{"DOI":"10.1016\/j.jiac.2024.06.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000}}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22002409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22002409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T07:19:22Z","timestamp":1665472762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22002409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1341321X22002409"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.08.014","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jiac.2024.06.008","asserted-by":"object"}]},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activity of ozenoxacin and other antimicrobials against Staphylococcus aureus strains isolated from clinical skin specimens in Japan in 2019 and 2020","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}